[1]
Meske, PhD, D., Kopecky, PhD, E.A., Passik, PhD, S. and Shram, PhD, M.J. 2018. Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER). Journal of Opioid Management. 14, 5 (Sep. 2018), 359–372. DOI:https://doi.org/10.5055/jom.2018.0468.